Multiple Sclerosis Journal · 2014 · 52 citations · 8 references
Life SciencesNeurologyNeuroscienceAutoimmunityNeuroimmunologyNeuropathologyAntibody CharacterizationDemyelinating DiseasesIon Channel DisordersMultiple SclerosisFluorescent StainingImmunofluorescence AssaysImmunofluorescence DiagnosisImmunofluorescence FindingsImmunohistochemical StainingMultiple Sclerosis ImmunopathologyMultiple Sclerosis PathologyNeurological Pathogenesis
BACKGROUND: auto-antibodies against the potassium channel inward rectifying potassium channel 4.1 (Kir4.1) have previously been identified in 46% of patients with multiple sclerosis (MS). OBJECTIVES: to confirm these findings. METHODS: we evaluated the presence of anti-Kir4.1 antibodies by enzyme-linked immunosorbent assay (ELISA) and immunofluorescence in 268 MS patients, 46 patients with other neurological diseases (OND) and 45 healthy controls. RESULTS: anti-Kir4.1 antibodies were found in 7.5% of MS patients, 4.3% of OND patients and 4.4% of healthy controls. Immunofluorescence analysis did not identify any specific staining. CONCLUSIONS: we confirmed the presence of anti-Kir4.1 antibodies in MS patients, but at a much lower prevalence than previously reported.
8
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · Annals of Neurology · 2011 · 9.8K citations · Full text
Medicine, Neurology, Neuroscience +10
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Vanda A. Lennon, Dean M. Wingerchuk, Thomas J. Kryzer et al. · The Lancet · 2004 · 3.2K citations
Life Sciences, Immunology, Neurology +14